Our vision is to bring a paradigm change to the management of brain disorders and injuries,
by transforming state of the art neuroscience into bed-side clinical practice. BNA™  is cleared by the FDA for marketing in the US.

BNA™ in a nutshell

ElMindA’s BNA™ technology is based on non-invasive recordings of multi-channel ERPs, a direct measure of neural activity, and a comprehensive and advanced analysis of these recordings to form Brain Network Activation patterns (BNAs) in order to map neural pathways that …

Read More

Drug development

BNA™ serves as a valuable tool in CNS drug development, providing the means to quantify drug-induced neuro-physiological changes in brain network activity. The BNA™ technology has been adopted by major pharmaceutical companies for drug development.

Read More
football player catches ball in midair


The BNA™ technology can potentially serve as an objective tool for patient evaluation and management during the recovery from a concussion, by providing objective and direct metrics of the brain’s neuro-physiological changes. The technology has attracted top key opinion leaders in concussion.

Read More